The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Leonard Frank X since 2021.
This trader's CIK number is 1822879.
At the time of last reporting, Leonard Frank X was the EVP, Pres., Novocure Oncology of Novocure Ltd. (stock ticker symbol NVCR).
Also see all insider trading activities at Novocure Ltd.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NVCR | 0 | $0 | 17,563 | $345,688 | 0 | $0 |
| 2024 | NVCR | 0 | $0 | 2,676 | $43,075 | 0 | $0 |
| 2023 | NVCR | 0 | $0 | 61,810 | $6,156,579 | 35,209 | $530,106 |
| 2022 | NVCR | 0 | $0 | 91,014 | $7,761,146 | 27,585 | $197,230 |
| 2021 | NVCR | 0 | $0 | 3,343 | $473,605 | 1,465 | $218,431 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-03 | NVCR | Sale | 2,527 | 18.54 | 46,840 |
| 2025-02-27 | NVCR | Sale | 12,266 | 20.23 | 248,202 |
| 2025-02-28 | NVCR | Sale | 2,770 | 18.28 | 50,646 |
| 2024-11-01 | NVCR | Sale | 598 | 15.94 | 9,530 |
| 2024-02-28 | NVCR | Sale | 2,078 | 16.14 | 33,545 |
| 2023-03-07 | NVCR | Sale | 8,318 | 75.30 | 626,303 |
| 2023-03-03 | NVCR | Sale | 5,291 | 76.16 | 402,957 |
| 2023-03-02 | NVCR | Sale | 844 | 75.28 | 63,534 |
| 2023-03-03 | NVCR | Sale | 2,059 | 77.64 | 159,858 |
| 2023-03-02 | NVCR | Sale | 4,107 | 75.69 | 310,846 |
| 2023-03-01 | NVCR | Sale | 1,684 | 76.36 | 128,593 |
| 2023-01-05 | NVCR | Option Ex | 35,209 | 15.06 | 530,106 |
| 2023-01-05 | NVCR | Sale | 39,507 | 113.00 | 4,464,488 |
| 2022-10-06 | NVCR | Sale | 6,754 | 84.37 | 569,834 |
| 2022-09-29 | NVCR | Sale | 6,754 | 77.35 | 522,421 |
| 2022-09-22 | NVCR | Sale | 6,754 | 77.00 | 520,058 |
| 2022-09-22 | NVCR | Sale | 6,754 | 77.00 | 520,058 |
| 2022-09-15 | NVCR | Option Ex | 5,517 | 7.15 | 39,446 |
| 2022-09-15 | NVCR | Sale | 12,271 | 88.66 | 1,087,885 |
| 2022-09-15 | NVCR | Option Ex | 5,517 | 7.15 | 39,446 |
| 2022-09-15 | NVCR | Sale | 12,271 | 88.66 | 1,087,885 |
| 2022-09-15 | NVCR | Option Ex | 5,517 | 7.15 | 39,446 |
| 2022-09-15 | NVCR | Sale | 12,271 | 88.66 | 1,087,885 |
| 2022-09-15 | NVCR | Option Ex | 5,517 | 7.15 | 39,446 |
| 2022-09-15 | NVCR | Sale | 12,271 | 88.66 | 1,087,885 |
| 2022-09-15 | NVCR | Option Ex | 5,517 | 7.15 | 39,446 |
| 2022-09-15 | NVCR | Sale | 12,271 | 88.66 | 1,087,885 |
| 2022-08-02 | NVCR | Sale | 414 | 69.66 | 28,838 |
| 2022-03-08 | NVCR | Sale | 744 | 70.10 | 52,154 |
| 2022-03-03 | NVCR | Sale | 930 | 74.50 | 69,283 |
| 2022-03-04 | NVCR | Sale | 555 | 70.41 | 39,075 |
| 2021-09-02 | NVCR | Sale | 540 | 138.23 | 74,645 |
| 2021-08-02 | NVCR | Sale | 713 | 149.38 | 106,506 |
| 2021-08-03 | NVCR | Sale | 328 | 149.43 | 49,013 |
| 2021-03-08 | NVCR | Sale | 765 | 130.81 | 100,066 |
| 2021-03-04 | NVCR | Sale | 567 | 137.55 | 77,993 |
| 2021-03-02 | NVCR | Sale | 430 | 152.05 | 65,382 |
| 2021-02-27 | NVCR | Option Ex | 1,465 | 149.10 | 218,431 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Leonard Frank X (EVP, Pres., Novocure Oncology of Novocure Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.